stockrowRapport Therapeutics, Inc. (RAPP) vs Verastem, Inc. (VSTM)
- Rapport Therapeutics, Inc. RAPP 24.48 +3.20%
- Verastem, Inc. VSTM 8.43 −10.13%
Rapport Therapeutics, Inc. and Verastem, Inc. are both Biotechnology companies. Rapport Therapeutics, Inc. and Verastem, Inc. are of similar size ($1.1B and $1.1B). Rapport Therapeutics, Inc. has the higher net margin (0.00% vs −178.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Rapport Therapeutics, Inc. leads on 10 and Verastem, Inc. on 2.
Valuation
Profitability
| Metric | RAPP | VSTM | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 68.51% |
| Operating margin | 0.00% | (193.73%) | 0.00% |
| Net margin | 0.00% | (178.38%) | 0.00% |
| Free cash flow margin | 0.00% | (159.10%) | 0.00% |
| Return on equity | (33.33%) | 6,595.50% | (51.96%) |
| Return on assets | (31.55%) | (88.02%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack